Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo

Cancer Gene Therapy

Volumn 8, Issue 11, 2001, Pages 869-878

  Rigg, A S ^a   Lemoine, N R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Adenovirus; Gene therapy; Pancreatic cancer; Tissue inhibitor of metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSGENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSGENES; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; DNA VIRUSES; MURINAE; MUS MUSCULUS;

EID: 0035183055     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700387     Document Type: Article

References (39)

1. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion metastasis
2. The matrix-degrading metalloproteinases
3. Molecular framework for angiogenesis: A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines
4. The matrix metalloproteinases and their inhibitors
5. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
6. Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family
7. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
8. Murine tissue inhibitor of metalloproteinases 4 (TIMP-4): cDNA isolation and expression in adult mouse tissues
9. Expression and in situ localization of genes encoding for extracellular matrix degrading proteases in pancreatic cancer
10. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas
11. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
12. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells
13. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases
14. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor
15. Tumor cell invasion inhibited by TIMP-2
16. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
17. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinase-1
18. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
19. Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion
20. Overexpression of metalloproteinase inhibitor in B16F10 cels does not affect extravasation but reduces tumor growth
21. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
22. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
23. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2
24. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
25. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
26. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
27. Induction of angiogenesis in chick yolk sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)
28. Adenoviral vectors
29. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
30. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
31. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointimal formation in human saphenous veins
32. Inhibition of late vein graft neointimal formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
33. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1
34. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir
35. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity
36. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex thymidine kinase gene
37. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene
38. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine lewis lung carcinoma